DR. TIMOTHY ALLEN LONESKY D.O. NPI 1447478029

NPI Information

  • NPI: 1447478029
  • Provider Name: DR. TIMOTHY ALLEN LONESKY, D.O.
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 26 OXFORD WAY
    SUITE C
    SOMERSET, KY
    ZIP 42503
  • Phone: (606) 802-2300

Map and Directions

Get Directions

NPI Details

DR. Timothy Allen Lonesky, D.O. is a rheumatology internal medicine in Somerset, KY with 22 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. Timothy Allen Lonesky, D.O. NPI is 1447478029. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE
Graduation Year:2004

The provider's business location address is:

26 OXFORD WAY
SUITE C
SOMERSET, KY
ZIP 42503-813
Phone: (606) 802-2300
Fax: (606) 802-2400

The NPI 1447478029 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, rituximab, 10 mg (HCPCS:J9312)
  • Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
  • Injection, infliximab-abda, biosimilar, (renflexis), 10 mg (HCPCS:Q5104)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Analysis of substance using immunoassay technique, multiple step method (HCPCS:83516)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Measurement of dna antibody, single stranded (HCPCS:86226)
  • Tuberculosis test, gamma interferon (HCPCS:86480)
  • Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Measurement of dna antibody, native or double stranded (HCPCS:86225)
  • Screening test for autoimmune disorder (HCPCS:86038)
  • Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
  • Rheumatoid factor level (HCPCS:86431)
  • Vitamin d-3 level (HCPCS:82306)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Hyaluronan or derivative, gel-one, for intra-articular injection, per dose (HCPCS:J7326)
  • Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
  • Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Injection, methylprednisolone acetate, 20 mg (HCPCS:J1020)
  • Aspiration and/or injection of fluid from small joint (HCPCS:20600)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)

The enumeration date for this NPI number is 4/21/2007 and was last updated on 10/29/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal Medicine03160KENTUCKYNo
2207RR0500XInternal MedicineRheumatology03160KENTUCKYYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.